Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide injection vs Novo Nordisk Victoza in type 2 diabetes
CTR20190791Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Apr 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Tonghua Dongbao. Started Apr 2019; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190791.